Evidence map›Paper›PMID 42718640›Full record

ArticleOphthalmology science2026

Twelve-Year Incidence, Causes, and Determinants of Visual Impairment and Visual Improvement in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study.

Gabriel Dawei Yang, Can Can Xue, Miao Li Chee, Zhi Da Soh, Qingsheng Peng, Jocelyn Hui Lin Goh, Zhi Wei Lim, Miao Ling Chee, Hongyu Wei, Yanyan Chen and 3 more

Abstract read
In one paragraph

Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gabriel Dawei YangSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Can Can XueSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Miao Li CheeSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Zhi Da SohSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Qingsheng PengSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Jocelyn Hui Lin GohSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Zhi Wei LimDepartment of Ophthalmology, National University Hospital, National University of Health System, Singapore, Singapore.
Miao Ling CheeSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Hongyu WeiSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Yanyan ChenSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Charumathi SabanayagamSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Ching-Yu ChengSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Yih Chung ThamSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To determine the 12-year incidence of visual impairment (VI) and visual improvement, associated risk factors and primary causes of VI in a multiethnic Asian population. Design: Population-based study. Participants: Of 10 033 adults aged 40-80 years recruited at baseline from the Singapore Epidemiology of Eye Diseases (SEED) study, 5841 eligible participants were contacted for 12-year re-examination. A total of 4495 (response rate 76.96%; 1302 Malays, 1555 Indians, 1638 Chinese) attended follow-up. Methods: Best-corrected visual acuity (BCVA) and presenting visual acuity (PVA) were assessed at baseline and 12-year follow-up. Incident VI (low vision and blindness) was defined using US criteria based on the better-seeing eye. Age-standardized incidence rates were calculated. Visual improvement was defined as transition to a less severe VI category. Poisson regression with robust variance estimated associations between baseline factors and incident VI. Population attributable fractions (PAFs) were computed for significant determinants. Main Outcome Measures: Twelve-year incidence of VI and rate of visual improvement. Results: Over 12 years, age-standardized incidence of best-corrected VI was 3.5% (95% confidence interval [CI], 2.8%-4.4%) and presenting VI was 8.1% (95% CI, 7.0%-9.4%). Incidence increased with age and was higher among women and Malay participants. Cataract was the leading cause of incident best-corrected VI (62.7%), whereas under-corrected refractive error predominated for presenting VI (46.2%). Older age (per decade, RR = 2.06), Malay ethnicity (vs Chinese, RR=2.12), diabetes (RR = 1.90), chronic kidney disease (RR = 1.70), low income (Over 12 years, the age-standardized incidence of best-corrected VI was 3.5% (95% confidence interval [CI], 2.8%-4.4%), and presenting VI was 8.1% (95% CI, 7.0%-9.4%). Incidence increased with age and was higher among women and Malay participants. Cataract was the leading cause of incident best-corrected VI (62.7%), whereas under-corrected refractive error predominated for presenting VI (46.2%). Older age (per decade, relative risk [RR] = 2.06), Malay ethnicity (vs Chinese, RR = 2.12), diabetes (RR = 1.90), chronic kidney disease (RR = 1.70), low income (<SGD$2000, RR = 2.52), and no formal education (RR = 2.14) were independently associated with incident best-corrected VI (all Conclusions: In this multiethnic Asian cohort, the 12-year burden of VI is largely driven by preventable or treatable causes, particularly cataract and refractive error. A significant proportion of individuals experienced visual improvement over 12 years, highlighting the substantial reversibility of vision loss. Socioeconomic disadvantage was a major determinant of incident VI, reinforcing the need for targeted, equitable eye-care interventions to reduce avoidable vision loss in ageing populations. Financial Disclosures: The authors have no proprietary or commercial interest in any materials discussed in this article.

Indexed as

IncidencePopulation-basedSingapore Epidemiology of Eye Diseases (SEED)Visual impairmentVisual improvement

Identifiers

PMID42718640
PMCPMC13553562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.